ICAM1 and diabetic kidney disease: Taking together the evidence from genetic studies and biochemical functional analyses, we propose that the heterozygous carriers of the ICAM1 E469K polymorphism among the patients with DKD have increased circulating ICAM-1 protein, while the formation of ICAM-1 protein and related biological function are changed.